BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 12369132)

  • 1. [Minimal-change disease with mesangial IgA deposits associated with Sjogren syndrome].
    Mon C; Sánchez Hernández R; Fernández Reyes MJ; Estébanez C; Ortiz M; Alvarez-Ude F; Mampaso F
    Nefrologia; 2002; 22(4):386-9. PubMed ID: 12369132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Sjögren's syndrome with minimal change disease--a case report.
    Yang ML; Kuo MC; Ou TT; Chen HC
    Kaohsiung J Med Sci; 2011 May; 27(5):190-4. PubMed ID: 21527186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amicrobial pustulosis associated with autoimmune disease in a patient with Sjögren syndrome and IgA nephropathy.
    Lim YL; Ng SK; Lian TY
    Clin Exp Dermatol; 2012 Jun; 37(4):374-8. PubMed ID: 22300247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjogren's syndrome complicated with IgA nephropathy and leukocytoclastic vasculitis.
    Tsai TC; Chen CY; Lin WT; Lee WJ; Chen HC
    Ren Fail; 2008; 30(7):755-8. PubMed ID: 18704825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
    Tsunehisa N; Takemura T; Inui T; Kamiya H
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy with minimal change disease.
    Herlitz LC; Bomback AS; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1033-9. PubMed ID: 24721885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amicrobial pustulosis associated with IgA nephropathy and Sjögren's syndrome.
    Natsuga K; Sawamura D; Homma E; Nomura T; Abe M; Muramatsu R; Mochizuki T; Koike T; Shimizu H
    J Am Acad Dermatol; 2007 Sep; 57(3):523-6. PubMed ID: 17599665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kimura disease: a case report and review of the Chinese literature.
    Wang DY; Mao JH; Zhang Y; Gu WZ; Zhao SA; Chen YF; Liu AM
    Nephron Clin Pract; 2009; 111(1):c55-61. PubMed ID: 19052471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary and secondary glomerular diseases].
    Benck U; Banas B; Birck R
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2520-2. PubMed ID: 25423461
    [No Abstract]   [Full Text] [Related]  

  • 10. IgA nephropathy with minimal change disease associated with primary Sjögren's syndrome: A case report.
    Choi J; Lee TW; Bae E; Jang HN; An HJ; Chang SH; Park DJ
    Medicine (Baltimore); 2023 Jun; 102(22):e33892. PubMed ID: 37266627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].
    Tsukada M; Honda K; Nitta K; Yumura W; Nihei H
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):681-8. PubMed ID: 14631763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren's syndrome.
    Yamanaka M; Fujigaki Y; Kono H; Nagura M; Arai S; Tamura Y; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S
    CEN Case Rep; 2018 Nov; 7(2):211-216. PubMed ID: 29671215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal change disease versus IgA nephropathy.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):116-9. PubMed ID: 19112229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
    Hamaguchi K; Tuchida H; Suzuki S; Miura Y; Nakazawa R; Suhara Y; Mimura N
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjögren's syndrome: a case report.
    Nishioka R; Hara S; Kawahara H; Ito K; Mizushima I; Hirata M; Nagata M; Kawano M
    BMC Nephrol; 2021 Mar; 22(1):108. PubMed ID: 33765955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sjogren syndrome: a review of the literature and a case report].
    Claeys V; Wackens G
    Rev Belge Med Dent (1984); 2006; 61(3):161-72. PubMed ID: 17408137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible minimal change nephrotic syndrome and glomerular IgA deposition associated with nonparenteral heroin abuse: a case report.
    Turgutalp K; Kiykim A; Karabulut U; Gursoy D; Gurses I
    Med Princ Pract; 2012; 21(5):492-4. PubMed ID: 22539034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
    Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
    Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic indicators and treatment of childhood IgA nephropathy.
    Hogg RJ
    Contrib Nephrol; 1995; 111():194-9; discussion 199-200. PubMed ID: 7758342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Crescentic glomerulonephritis and primary Gougerot-Sjögren syndrome].
    Dussol B; Tsimaratos M; Bolla G; Harlé JR; Brunet P; Casanova P; Weiller PJ; Berland Y
    Nephrologie; 1994; 15(4):295-8. PubMed ID: 7984249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.